Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases
Friday, February 19, 2021Eli Lilly and Company and Rigel Pharmaceuticals Inc announced a global exclusive license agreement and strategic collaboration to codevelop and commercialize Rigels R a receptorinteracting serinethreonineprotein kinase RIPK inhibitor
Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists
Friday, February 19, 2021Boston Immune Technologies and Therapeutics Inc BITT a privately held developer of novel antagonist antibodies for cancer and other diseases and BeiGene Ltd announced that they have entered into an option and license agreement aimed at developing and...
Provention Bio and Huadong Announce Strategic Collaboration to Develop and Commercialize PRV-3279 in Greater China
Thursday, February 18, 2021Provention Bio Inc a biopharmaceutical company dedicated to intercepting and preventing immunemediated diseases and Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd a whollyowned subsidiary of Huadong Medicine Co Ltd
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
Thursday, February 18, 2021GlaxoSmithKline plc and Vir Biotechnology Inc announced they have signed a binding agreement to expand their existing collaboration to include the research and development of new therapies for influenza and other respiratory viruses
AliveCor Announces Collaboration with AstraZeneca to Develop Non-Invasive Potassium Monitoring Solutions
Wednesday, February 17, 2021AliveCor the leader in AIbased personal ECG technology and provider of enterprise cardiology solutions announced a new collaboration with AstraZeneca a global scienceled biopharmaceutical company
Iterion Therapeutics Secures $17 Million to Advance Development of Tegavivint in Multiple Tumor Settings
Wednesday, February 17, 2021Iterion Therapeutics Inc Iterion a venturebacked clinical stage biotechnology company developing novel cancer therapeutics announced that it has raised million USD in a Series B financing led by Lumira Ventures
SHEPHERD Therapeutics and Oncoheroes Biosciences to Partner for the Discovery, Development and Commercialization of Oncology Therapeutics For Rare Cancers
Tuesday, February 16, 2021SHEPHERD Therapeutics a company dedicated to catalyzing lifesaving treatments for rare cancer patients and Oncoheroes Biosciences a biotech company focused on advancing new therapies for childhood cancer
Avexegen Therapeutics Receives a $2.94M NIH Grant to Advance Treatment for Inflammatory Bowel Disease
Tuesday, February 16, 2021Avexegen Therapeutics Incannounced that it has received a Phase award of million under the National Institutes of Healths Small Business Innovation Research Program SBIR for the development of an oral Neuregulinbased therapy for inflammatory bowel...
FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy
Monday, February 15, 2021The US Food and Drug Administration approved Cosela trilaciclib as the first therapy in its class to reduce the frequency of chemotherapyinduced bone marrow suppression in adults receiving certain types of chemotherapy for extensivestage
Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies
Friday, February 12, 2021Molecular Templates Inc announced that it has entered into a worldwide strategic research collaboration with Bristol Myers Squibb to discover and develop multiple novel therapies designed for specific oncology targets
